In support of the impact of epigenome influence on BC, inhibition of PI3K pathway was reported to lead to activation of ER-dependent transcription through the epigenetic regulator KMT2D, identified as the key determinant [100]. The gene discussed is PIK3CA; the disease is breast cancer.